Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype - Concepedia

Concepedia

Publication | Open Access

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype

DOI Full Paper Access

28

Citations

21

References

2023

Year

Benjamin Terrier, David Jayne, Bernhard Hellmich, Jane H. Bentley, Jonathan Steinfeld, Steven W. Yancey, Namhee Kwon, Praveen Akuthota, Paneez Khoury, Lee Baylis,

ACR Open Rheumatology

Abstract

Mepolizumab is associated with clinical benefits for patients with and without a vasculitic EGPA phenotype.

References

	Year	Citations

Page 1